SUPERNUS PHARMACEUTICALS, INC. 4

Timothy C. Dec, Senior Vice-President & CFO of Supernus Pharmaceuticals, Inc. (SUPN), received 1,250 shares of common stock upon vesting of performance share units.

On July 29, 2026, Senior Vice-President & CFO Timothy C. Dec of Supernus Pharmaceuticals, Inc. acquired 1,250 shares of common stock upon the vesting of previously granted Performance Share Units that were awarded on February 19, 2025 and tied to individual performance objectives established on May 3, 2025. The transaction was reported as an acquisition from a performance share unit award rather than an open-market trade, and is routine equity-based compensation; pricing information was not disclosed in the Form 4, so the exact dollar value of both the award and Mr. Dec’s post-transaction ownership cannot be calculated from the filing alone.

Filing Facts

CIK

1356576

Ticker

SUPN

Form

4

Source Type

fda

Accession

0001194020-26-000013

Alert Tier

4